Repositive Limited

Overview

Legal name

REPOSITIVE LIMITED

Region

South East England

Registered address

Unknown

Insolvency history

Yes

Company events

Reference milestones and recent Companies House filing stream events.

2 events

05 Sep

2024

Gazette Dissolved Liquidation

Gazette

GAZ2 | Transaction MzQzNDYyOTA3MGFkaXF6a2N4 | Paper/PDF filed

Published 07 Sep 2024 06:01

19 Dec

2013

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2015

Funded years

2015, 2017

Age at first award

1 years

Projects

2017 Feasibility Studies Lead participant

REPOSITIVE LIMITED: INTERNATIONAL DEVELOPMENT PROGRAMME TO INCREASE THE IMPACT OUR ONLINE PLATFORM FOR QUERYING AND ACCESS TO MOLECULAR DATA ON PATIENT DERIVED XENOGRAFT MODELS.

1 Jan 2017 to 31 Mar 2017

Awarded

£20,978

Total cost £29,968

Patient derived xenograft (PDX) models are powerful tools used by scientists studying cancer and in discovery of new cancer treatments. Each one is grown from a sample of a cancerous tumour donated by a cancer sufferer: so they are precious, valuable and useful. But scientists find it hard to find suitable ones for their work and so many spend a lot of ti...

2015 GRD Proof of Concept Lead participant

REPOSITIVE LTD: DEVELOPMENT OF A PROTOTYPE “PRIVACY PRESERVING QUERY ENGINE” – FOR SECURE QUERYING OF CONFIDENTIAL GENOMICS DATABASES, TO ENABLE EFFICIENT AND ETHICAL DATA SHARING FOR PRECISION MEDICINE, DISEASE DIAGNOSIS AND GENOMICS RESEARCH.

1 Aug 2015 to 31 Jan 2016

Awarded

£52,292

Total cost £87,154

REPOSITIVE LIMITED is developing bioinformatics and web tools to overcome the barriers to access to human genome sequencing data to support new development in medical research, diagnostics and development of new cures. We are developing repositive.io, our online platform and web application for collaborative data discovery, metadata management tools, secu...

Product types

Feasibility Studies GRD Proof of Concept